HealthMyne company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Loan | Alive

Total Raised


Last Raised

$680K | 2 yrs ago

About HealthMyne

HealthMyne is a healthcare IT company that brings evidence-based imaging analysis and insights to radiologists and oncologists at the point of care. The company's approach to clinical imaging enables healthcare providers to optimize individual patient care, while lowering overall care cost.

HealthMyne Headquarter Location

918 Deming Way 3rd Floor

Madison, Wisconsin, 53717,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing HealthMyne

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

HealthMyne is included in 6 Expert Collections, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Conference Exhibitors

5,302 items



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Digital Health

13,084 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

2,281 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

HealthMyne Patents

HealthMyne has filed 3 patents.

The 3 most popular patent topics include:

  • Computer vision
  • Image processing
  • Medical imaging
patents chart

Application Date

Grant Date


Related Topics




Medical imaging, Image processing, Computer vision, 3D imaging, Elementary geometry


Application Date


Grant Date



Related Topics

Medical imaging, Image processing, Computer vision, 3D imaging, Elementary geometry



Latest HealthMyne News

08:20 ET HealthMyne's Radiomic Technology Leveraged to Identify Biomarkers That Predict Immunotherapy Treatment Responses

Sep 21, 2021

Peer-reviewed research published in Cancers demonstrates radiomics ability to pinpoint lung adenocarcinoma patients who would benefit from immunotherapy News provided by Share this article Share this article MADISON, Wis., Sept. 21, 2021 /PRNewswire/ --  HealthMyne , a pioneer in applied radiomics, announced today that peer-reviewed research  recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients with lung adenocarcinoma would benefit from immunotherapy. In the Cancers article, researchers led by Vincenza Granata evaluated HealthMyne's technology as a quantitative imaging decision support tool for radiomic analysis of lung adenocarcinoma in chest CT scans. Researchers analyzed radiomic biomarkers to predict Overall Survival (OS) and Progression Free Survival (PFS) time. To perform the study, researchers selected 74 patients with histologically confirmed lung cancer who underwent immunotherapy and compared them with 50 patients with histologically confirmed lung adenocarcinoma who underwent chemotherapy alone or in combination with targeted therapy. Researchers segmented each patient's lesion leveraging HealthMyne's advanced imaging analytics solution to extract 573 radiometric metrics from the cohort images to predict OS and PFS time. Researchers found that 19 radiomic features were significant for predicting OS and 108 radiomic features for predicting PFS time. Researchers concluded that the study demonstrated the relationship between radiomics and immunotherapeutic response and that specific radiomic features can be used to select patients with lung adenocarcinoma who would benefit from immunotherapy. "To maximize the value of research and development investments, drug developers need an accurate and efficient means of selecting and stratifying patients for clinical studies," said Rose Higgins, CEO, HealthMyne. "Numerous examples of peer-reviewed research have shown that radiomics and precision image analysis identifies biomarkers that drive greater personalization of treatment and provides new insights for better decisions. At HealthMyne, we strive to develop innovative radiomic solutions that contribute to the advancement of this critical body of evidence." About HealthMyne  HealthMyne® is a pioneer in applied radiomics, the cutting-edge field of extracting novel data and biomarkers from medical images. Our FDA-approved and CE marked, AI-enabled solutions allow organizations to easily access and translate groundbreaking radiomic insights into use in research, clinical outcomes, and treatment pathways. By leveraging radiomics, our clients and partners can accelerate the development and delivery of the best possible treatments. HealthMyne's approach is based upon the premise that every cancer patient's story begins with an image. We believe that unleashing the hidden power of imaging data and radiomics will revolutionize personalized care -- ensuring the right treatment every time. Our mission is to advance precision health initiatives through accessible and translatable radiomic data. Media Contact:

HealthMyne Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

HealthMyne Rank

  • Where is HealthMyne's headquarters?

    HealthMyne's headquarters is located at 918 Deming Way, Madison.

  • What is HealthMyne's latest funding round?

    HealthMyne's latest funding round is Loan.

  • How much did HealthMyne raise?

    HealthMyne raised a total of $23.28M.

  • Who are the investors of HealthMyne?

    Investors of HealthMyne include Paycheck Protection Program, Venture Investors, 4490 Ventures, Alumni Ventures, Ascension Ventures and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.